|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▼
|
Status ▲
|
|
SPARSENTAN |
C09XX01 |
DE
|
POM
|
27-11-2024 |
EMEA/H/C/005783 |
19-04-2024 |
VALID
|
|
ETRASIMOD |
L04AE05 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
ADAGRASIB |
L01XX77 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
DE
|
POM
|
13-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
FUTIBATINIB |
L01EN04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005627 |
04-07-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B06XX00 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
MARIBAVIR |
J05AX10 |
DE
|
I
|
14-11-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
MITAPIVAT |
B06AX04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005681 |
17-08-2022 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
CAPMATINIB |
L01EX17 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
LINZAGOLIX |
H01CC04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005442 |
14-06-2022 |
VALID
|
|
RELUGOLIX |
L02BX04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
INEBILIZUMAB |
L04AG10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
